EDUCATION
B.S., 1972, University of Georgia
M.D. (Medicine) 1976, Medical College of Georgia

PROFESSIONAL CERTIFICATION
Licensed Physician, State of New Mexico

EMPLOYMENT

PROFESSIONAL AFFILIATIONS
New Mexico Medical Society
Greater Albuquerque Medical Association

REPRESENTATIVE RESEARCH PROJECTS

1. A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of (study drug) Phosphate Modified Release Formulation (study drug) with (study drug) on the Lipid Profile in Normolipidemic, or Mildly Dyslipidemic Hypertensive Patients, 2006.

    

2. A 52-Week Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Clinical Trial, to Assess the Efficacy and Safety of 200 mg of the Anti-cholinergic (study drug) Compared to Placebo, Both Administered Once-Daily by Inhalation, in the Maintenance Treatment of Patients with Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease, 2006.

    

3. A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Three Doses of (study drug) in Abdominally Obese Patients with Atherogenic Dyslipidemia, 2006.

    

4. A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either (study drug) or (study drug) in Subjects who are at Risk for Developing NSAID-Associated Ulcers, 2006.

    

5. A Phase IV Randomised, Double-Blind, Active and Placebo-Controlled, 6-Week Trial to Investigate the Efficacy and Safety of a Starting (and Fixed) Dose of 0.25 mg (study drug) in Patients with Idiopathic Restless Legs Syndrome, 2006.

    

6. A Randomized, Double-Blind, Active Control, Parallel Arm, 90 Day Safety Study of (study drug) Immediate Release (IR) or Oxycodone IR in Subjects with Chronic Pain from Low Back Pain (LBP) or Osteoarthritis (OA) of the Hip or Knee, 2006.

    

7. A Phase 3, 24-Week, Multi-center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of (study drug) in Combination with Metformin or (study drug) Alone versus 2 Oral Anti-diabetic Agents (Metformin and a Secretagogue) in Subjects with Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue, 2006.

    

8. A 104-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of (study drug) in Obese Patients, 2006.

    

9. A Trial to Evaluate the Safety and Efficacy of (study drug) Combined with (study drug) in Patients with Chronic Obstructive Pulmonary Disease, 2006.

    

10. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Tolerability of (study drug) for a Single Moderate or Severe Headache in Adults Diagnosed with Probable Migraine without Aura, 2006.

     

11. A Comparison of (study drug) Delivered by the (study drug) Inhaler to (study drug) Inhalation Aerosol and (study drug) Delivered by the (study drug) in a 12-Week, Double-Blind, Safety and Efficacy Study in Adults with Chronic Obstructive Pulmonary Disease, 2006.

     

12. A Multicenter, Open-Label Study of the Safety and Efficacy of Long Term Use of (study drug) Extended Release (G-ER) Tablets in the Treatment of Patients with Postherpetic Neuralgia, 2006.

     

13. A Phase III, Multi-center, Open-Label, Extension Study of (study drug) for the Treatment of Fibromyalgia, 2006.

     

14. A Multi-center, Randomized, Open-Label, Active Controlled, Parallel Arm Study to Compare the Efficacy of 12 Weeks of Treatment with (study drug) 100 mg, qd to (study drug) as Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy in a Community-Based Practice Setting, 2006.

     

15. A Phase IIb/III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of (study drug) in Obese Patients and in Overweight Patients with Obesity-Related Co-mobidities Study, 2006.

     

16. A 2-Year, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Long-Term Dfficacy and Safety of (study drug) in the Treatment of Obese Subjects, 2006.

     

17. A Randomized, Multi-center, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Study to Assess Vigilance and Cognitive Function Upon Awakening in Patients with Seasonal Allergic Rhinitis after a Nighttime Dose of (study drug) or (study drug), 2006.

     

18. A Comparison of (study drug) Delivered by the (study drug) Inhaler to (study drug) Inhalation Aerosol and (study drug) Delivered by the (study drug) in a 12-Week, Double-Blind, Safety and Efficacy Study in Adults with Chronic Obstructive Pulmonary Disease, 2006.

     

19. A 1-Year, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of (study drug) in the Treatment of Overweight, Oral Agent-Treated Subjects with Type 2 Diabetes Mellitus, 2006.

     

20. A Long-Term, Open-Label, Safety Study of (study drug) Capsules in Subjects with Chronic Moderate to Severe Nonmalignant Pain, 2006.

     

21. A 54-Week, Open-Label, Multicenter Study to Assess the Long-Term Safety and Tolerability of the Combination of (study drug) 300 mg/(study drug) 10 mg in Patients with Essential Hypertension, 2006.

     

22. A Randomized, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Assess the Effect of (study drug) 20 and 40 mg od versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low-Dose Acetylsalicylic Acid (ASA), 2006.

     

23. A Multi-site, Cross-Sectional, Non-treatment, Prospective Trial to Collect Bio-fluids and Neuropsychiatric Data from Cognitively Normal Elderly Subjects, 2006.

     

24. A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of (study drug) Compared with Once-Daily Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus on Oral Agents, 2007.

     

25. A Randomized Double-Blind, Placebo- and Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of (study drug) Extended Release (ER) in Subjects with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee, 2007.